Why is Jenburkt Pharma falling/rising?

As of 10-Sep, Jenburkt Pharmaceuticals Ltd. is experiencing a decline in its stock price, currently at Rs 1,092.10, which reflects a decrease of Rs 24.95 or 2.23%. The stock has been underperforming, having fallen consecutively for the last three days, resulting in a total decline of 7.66% during this period. Today's trading saw the stock reach an intraday high of Rs 1,140 but also dip to a low of Rs 1,080. It is noteworthy that the stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Despite this downturn, there has been a significant increase in investor participation, with delivery volume rising by 146.43% compared to the 5-day average. The company maintains a high management efficiency with a return on equity (ROE) of 18.49% and a low debt-to-equity ratio, which are positive indicators, yet the stock's recent performance suggests investor sentiment is currently negative. In the broader market context, Jenburkt Pharmaceuticals has underperformed relative to the Sensex, with a 1-week return of -8.07% compared to the benchmark's gain of +1.06%. Over the past month, the stock has also declined by 8.67%, while the Sensex has increased by 1.96%. This stark contrast highlights the stock's struggles in the current market environment. The company's recent performance, combined with its strong fundamentals, suggests that while there are positive aspects to its financial health, the market's reaction has been unfavorable, leading to the observed decline in stock price.